Reduced SARS-CoV-2 infection and death after two doses of COVID-19 vaccines in a series of 1503 cancer patients

Detalles Bibliográficos
Autores principales: Heudel, P., Favier, B., Assaad, S., Zrounba, P., Blay, J.-Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society for Medical Oncology. Published by Elsevier Ltd. 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321960/
https://www.ncbi.nlm.nih.gov/pubmed/34333128
http://dx.doi.org/10.1016/j.annonc.2021.07.012
_version_ 1783730946601648128
author Heudel, P.
Favier, B.
Assaad, S.
Zrounba, P.
Blay, J.-Y.
author_facet Heudel, P.
Favier, B.
Assaad, S.
Zrounba, P.
Blay, J.-Y.
author_sort Heudel, P.
collection PubMed
description
format Online
Article
Text
id pubmed-8321960
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher European Society for Medical Oncology. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-83219602021-07-30 Reduced SARS-CoV-2 infection and death after two doses of COVID-19 vaccines in a series of 1503 cancer patients Heudel, P. Favier, B. Assaad, S. Zrounba, P. Blay, J.-Y. Ann Oncol Letter to the Editor European Society for Medical Oncology. Published by Elsevier Ltd. 2021-11 2021-07-30 /pmc/articles/PMC8321960/ /pubmed/34333128 http://dx.doi.org/10.1016/j.annonc.2021.07.012 Text en © 2021 European Society for Medical Oncology. Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Heudel, P.
Favier, B.
Assaad, S.
Zrounba, P.
Blay, J.-Y.
Reduced SARS-CoV-2 infection and death after two doses of COVID-19 vaccines in a series of 1503 cancer patients
title Reduced SARS-CoV-2 infection and death after two doses of COVID-19 vaccines in a series of 1503 cancer patients
title_full Reduced SARS-CoV-2 infection and death after two doses of COVID-19 vaccines in a series of 1503 cancer patients
title_fullStr Reduced SARS-CoV-2 infection and death after two doses of COVID-19 vaccines in a series of 1503 cancer patients
title_full_unstemmed Reduced SARS-CoV-2 infection and death after two doses of COVID-19 vaccines in a series of 1503 cancer patients
title_short Reduced SARS-CoV-2 infection and death after two doses of COVID-19 vaccines in a series of 1503 cancer patients
title_sort reduced sars-cov-2 infection and death after two doses of covid-19 vaccines in a series of 1503 cancer patients
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321960/
https://www.ncbi.nlm.nih.gov/pubmed/34333128
http://dx.doi.org/10.1016/j.annonc.2021.07.012
work_keys_str_mv AT heudelp reducedsarscov2infectionanddeathaftertwodosesofcovid19vaccinesinaseriesof1503cancerpatients
AT favierb reducedsarscov2infectionanddeathaftertwodosesofcovid19vaccinesinaseriesof1503cancerpatients
AT assaads reducedsarscov2infectionanddeathaftertwodosesofcovid19vaccinesinaseriesof1503cancerpatients
AT zrounbap reducedsarscov2infectionanddeathaftertwodosesofcovid19vaccinesinaseriesof1503cancerpatients
AT blayjy reducedsarscov2infectionanddeathaftertwodosesofcovid19vaccinesinaseriesof1503cancerpatients

Ejemplares similares